Erythroid and Megakaryocytic Differentiation Program in <i>JAK2</i>-Mutated Acute Myeloid Leukemia with or without Antecedent Myeloproliferative Neoplasm
Ying Liu, Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Shenon Sethi(Memorial Sloan Kettering Cancer Center), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Xiaotian Sun(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Robert Cimera(Memorial Sloan Kettering Cancer Center), Dory Londono(Memorial Sloan Kettering Cancer Center), Himanshu Bhurtel(Memorial Sloan Kettering Cancer Center), Jacob L. Glass(Memorial Sloan Kettering Cancer Center), Jeeyeon Baik, Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Deepika Dilip(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Massachusetts General Hospital), Pallavi Galera(National Institutes of Health Clinical Center), Tanmay Mishra(Vellore Institute of Technology University), Christopher Famulare(Memorial Sloan Kettering Cancer Center), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Menglei Zhu, Sonali Persaud(Memorial Sloan Kettering Cancer Center), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Qi Gao(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k